Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina

American Journal of Medicine

Volumn 124, Issue 8, 2011, Pages 681-688

  Deedwania, Prakash C ^a   Carbajal, Enrique V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary artery disease; Medical therapy; Revascularization; Stable angina

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; GLYCERYL TRINITRATE; IVABRADINE; NITRATE; PERINDOPRIL; PLACEBO; RAMIPRIL; RANOLAZINE; STATIN;

ADD ON THERAPY; ANGINA PECTORIS; CARDIAC PATIENT; CHRONIC DISEASE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERANCE; EDEMA; FATIGUE; FLUSHING; HEART DEATH; HUMAN; HYPOTENSION; LIFESTYLE MODIFICATION; MONOTHERAPY; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SIDE EFFECT; STABLE ANGINA PECTORIS; SURVIVOR; SYMPTOM; SYNCOPE; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME; UNITED STATES;

ACETANILIDES; ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HUMANS; HYPOLIPIDEMIC AGENTS; MYOCARDIAL REVASCULARIZATION; NITRATES; PIPERAZINES; TREATMENT OUTCOME;

EID: 79960751031     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.02.036     Document Type: Review

References (57)

1. R. Gibbons, J. Abrams, and K. Chatterjee ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina) www.acc.org/clinical/guidelines/stable/ stable.pdf 2002 Accessed November 15, 2010
2. K. Fox, M. Garcia, and D. Ardissino Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381 (Pubitemid 43998110)
3. R. Holubkov, W. Laskey, A. Haviland NHLBI Dynamic Registry. Registry Investigators Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry Am Heart J 144 2002 826 833 (Pubitemid 35335174)
4. J.S. Rumsfeld, D.J. Magid, and M.E. Plomondon History of depression, angina, and quality of life after acute coronary syndromes Am Heart J 145 2003 493 499 (Pubitemid 36390496)
5. J. Abrams Clinical practice Chronic stable angina N Engl J Med 352 2005 2524 2533 (Pubitemid 41007868)
6. J. Abrams, and U. Thadani Therapy of stable angina pectoris: the uncomplicated patient Circulation 112 2005 e255 e259
7. L.H. Opie, P.J. Commerford, and B.J. Gersh Controversies in stable coronary artery disease Lancet 367 2006 69 78
8. M.J. Reiter Cardiovascular drug class specificity: beta-blockers Prog Cardiovasc Dis 47 2004 11 33 (Pubitemid 39420270)
9. C. Pepine, P. Cohn, and P. Deedwania Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life The Atenolol Silent Ischemia Study (ASIST) Circulation 90 1994 762 768 (Pubitemid 24242742)
10. P. Poole-Wilson, J. Lubsen, and B. Kirwan A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial Lancet 364 2004 849 857 (Pubitemid 39221062)
11. D. Morrow, B. Scirica, E. Karwatowska-Prokopczuk MERLIN-TIMI 36 Trial Investigators Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783 (Pubitemid 46658646)
12. S. Wilson, B. Scirica, and E. Braunwald Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial J Am Coll Cardiol 53 2009 1510 1516
13. P. Dobesh, and T. Trujillo Ranolazine: a new option in the management of chronic stable angina Pharmacotherapy 27 2007 1659 1676 (Pubitemid 350234315)
14. P. Stone Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias Cardiol Clin 26 2008 603 614
15. G. Keating Ranolazine: a review of its use in chronic stable angina pectoris Drugs 68 2008 2483 2503
16. R. Joannides, N. Moore, and M. Iacob Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac hemodynamics at rest and during exercise Br J Clin Pharmacol 61 2006 127 137 (Pubitemid 43382606)
17. J. Borer, K. Fox, P. Jaillon, and G. Lerebours Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial Circulation 107 2003 817 823 (Pubitemid 36241038)
18. J. Tardif, I. Ford, M. Tendera, M. Bourassa, and K. Fox Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2005 2529 2536 (Pubitemid 41677303)
19. K. Fox, I. Ford, P. Steg, M. Tendera, R. Ferrari BEAUTIFUL Investigators Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
20. K. Swedberg, M. Komajda, M. Bohm SHIFT investigators Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study Lancet 376 2010 875 885
21. Effects of an angiotension-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
22. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
23. M. Al-Mallah, I. Tleyjeh, A. Abdel-Latif, and W. Weaver Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials J Am Coll Cardiol 47 2006 1576 1583
24. Scandinavian Simvastatin Survival Study group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
25. G. Schwartz, A. Olsson, M. Ezekowitz myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study investigators Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes The MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718 (Pubitemid 32259905)
26. B. Pitt, D. Waters, and W. Brown Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease Atorvastatin versus Revascularization Treatment Investigators N Engl J Med 341 1999 70 76 (Pubitemid 29314237)
27. P. Stone, D. Lloyd-Jones, S. Kinlay Vascular Basis Study Group Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study Circulation 111 2005 1747 1755 (Pubitemid 40525138)
28. P.C. Deedwania Study Assessing Goals in the Elderly steering committee and investigators Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE) Am Heart J 148 2004 1053 1059 (Pubitemid 39646983)
29. T. Pedersen, J. Kjekshus, and K. Pyörl Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S) Am J Cardiol 81 1998 333 335 (Pubitemid 28099310)
30. J. Deanfield, P. Sellier, and E. Thaulow Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? Eur Heart J 31 2010 2650 2659 Epub 2010 May 21
31. P. Deedwania, P. Stone, and N. Bairey Merz Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE) Circulation 115 2007 700 707 (Pubitemid 46294760)
32. W. Boden, R. O'Rourke, and K. Teo Optimal medical therapy with or without PCI for stable coronary disease COURAGE Trial Research Group N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
33. T. Takaro, H.N. Hultgren, K.M. Detre participants in the VA cooperative study VA cooperative study of coronary arterial surgery II. Left main disease Circulation 52 Suppl 2 1975 143 (abst)
34. T. Takaro, H.N. Hultgren, M.J. Lipton, and K.M. Detre The VA cooperative randomized study of surgery for coronary arterial occlusive disease II Subgroup with significant left main lesions Circulation 54 6 Suppl 1976 III107 II117
35. K. Detre Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group N Engl J Med 311 1984 1333 1339
36. P. Peduzzi, A. Kamina, K. Detre The VA coronary artery bypass surgery cooperative study group twenty-two-year follow-up in the VA cooperative study of coronary artery bypass surgery for stable angina Am J Cardiol 81 1998 1393 1399
37. T. Takaro, P. Peduzzi, and K. Detre Survival in subgroups of patients with left main coronary artery disease Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease Circulation 66 1982 14 22 (Pubitemid 12069951)
38. M. Murphy, H. Hultgren, K. Detre, J. Thomsen, T. Takaro participants of the Veterans Administration cooperative study Treatment of chronic stable angina A preliminary report of survival data of the randomized Veterans Administration cooperative study N Engl J Med 297 1977 621 627 (Pubitemid 8200047)
39. The VA coronary artery bypass surgery cooperative study group 18-year follow up in the Veterans Affairs cooperative study of coronary bypass surgery for stable angina Circulation 86 1992 121 130
40. European Coronary Surgery Study Group Coronary artery bypass surgery in stable angina pectoris: survival at two years Lancet 1 1979 889 893
41. E. Varnauskas Twelve-year follow-up of survival in the randomized European coronary surgery study N Engl J Med 319 1988 332 337
42. Prospective randomised study of coronary artery bypass surgery in stable angina pectoris Second interim report by the European coronary surgery study group Lancet 2 1980 491 495
43. European Coronary Surgery Study Group Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: a progress report on survival Circulation 65 1982 67 71
44. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris European Coronary Surgery Study Group Lancet 2 1982 1173 1180
45. E. Varnauskas Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery Circulation 72 6 Pt 2 1985 V90 V101
46. The principal investigators of CASS and their associates The national heart, lung and blood institute coronary artery surgery study (CASS) Circulation 63 Suppl-I 1981 I-1
47. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial N Engl J Med 310 1984 750 758
48. T. Killip, E. Passamani, and K. Davis Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery Eight years follow-up and survival in patients with reduced ejection fraction Circulation 72 6 Pt 2 1985 V102 V109
49. E. Alderman, M. Bourassa, and L. Cohen Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study Circulation 82 1990 1629 1646 (Pubitemid 20367965)
50. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery Survival data Circulation 68 1983 939 950
51. W. Hueb, G. Bellotti, and S. deOliveira The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses J Am Coll Cardiol 26 1995 1600 1605
52. W. Hueb, P. Soares, and S. Almeida DeOliveira Five-year follow-up of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis Circulation 100 19 Suppl 1999 II107 II113
53. The ACIP investigators Asymptomatic Cardiac Ischemia Pilot study (ACIP) Am J Cardiol 70 1992 744
54. W. Rogers, M. Bourassa, and T. Andrews Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization The ACIP Investigators J Am Coll Cardiol 26 1995 594 605
55. W. Hueb, P. Soares, and B. Gersh The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results J Am Coll Cardiol 43 2004 1743 1751 (Pubitemid 38622508)
56. R. Frye, P. August, and M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease BARI 2D Study Group N Engl J Med 360 2009 2503 2515
57. W. Weintraub, J. Spertus, P. Kolm COURAGE Trial Research Group Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 2008 677 687